Tongue hyperpigmentation during PEG-interferon-alfa/ribavirin therapy in a non-Caucasian patient with chronic hepatitis C: a case report and review of the literature-Reference-Cited by-同舟云学术

Tongue hyperpigmentation during PEG-interferon-alfa/ribavirin therapy in a non-Caucasian patient with chronic hepatitis C: a case report and review of the literature

Published:2012-10-09 Issue:5 Volume:52 Page:643-644
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:

Author:

Mlika Rym Benmously,Kerkeni Nadia,Marrak Hayet,Fenniche Samy,Mokhtar Inçaf,Debbiche Achraf

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-4632.2011.04921.x/fullpdf

Reference10 articles.

1. Cutaneous side-effects associated with interferon-alpha therapy: a review;Chang;Cutis,1995

2. Injection site vasculitis in a patient receiving interferon alpha for chronic hepatitis C;Christian;J Am Acad Dermatol,1997

3. Cutaneous necrosis after subcutaneous injection of polyethylene-glycol-modified interferon alpha;Kurzen;Acta Derm Venereol,2002

4. Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection;Willems;Br J Dermatol,2003

5. Tongue and skin hyperpigmentation during PEG-interferon-alpha/ribavirin therapy in dark-skinned non-Caucasian patients with chronic hepatitis C;Gurguta;Am J Gastroenterol,2006

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-induced Tongue Disorders: A Comprehensive Literature Review;Current Drug Safety;2024-05-23

2. Tongue Hyperpigmentation with Peginterferon α-2b Therapy in Hepatitis B: Case Series With Review of Literature;EMJ Hepatology;2024-05-08

3. Pigmented Fungiform Papillae (PFP) of the Tongue: A Systematic Review of Current Aetiopathogenesis and Pathophysiology;Pathophysiology;2022-09-09

4. Black hairy tongue during interferon therapy for hepatitis C;Annals of Hepatology;2015-05

5. Pigmentación oral asociada al tratamiento con alfa-interferón y ribavirina para la hepatitis C;Actas Dermo-Sifiliográficas;2014-03